title: Impact of a nutritional counseling program on prevention of HAART-related metabolic and morphologic abnormalities.
abstract: The advent of highly active antiretroviral therapy (HAART) improved HIV infection prognosis. However, adverse metabolic and morphologic effects emerged, highlighting a lack of investigation into the role of nutritional interventions among this population. The present study evaluated the impact of a nutritional counseling program on prevention of morphologic and metabolic changes in patients living with HIV/AIDS receiving HAART. A 12-month randomized clinical trial was conducted with 53 adults of both genders in use of HAART. Subjects were allocated to either an intervention group (IG) or a control group (CG). Nutritional counseling was based on the promotion of a healthy diet pattern. Anthropometrical, biochemical, blood pressure, and food intake variables were assessed on four separate occasions. Sub scapular skin-fold results showed a significant tendency for increase between time 1 (Mean IG = 14.9 mm; CG = 13.6 mm), time 3 (Mean IG = 16.7 mm; CG = 18.2 mm), and time 4 (Mean IG = 16.4 mm; CG = 17.7 mm). Lipid percentage intake presented a greater increase among controls (time 1 mean = 26.3%, time 4 mean = 29.6%) than among IG subjects (time 1 mean = 29.1%, time 4 mean = 28.9%). Moreover, participants allocated to the IG presented an increase in dietetic fiber intake of almost 10 grams. The proposed nutritional counseling program proved to be effective in improving diet by reducing fat consumption and increasing fiber intake.
authors.affiliation: School of Public Health, University of Sao Paulo, Avenida Doutor Arnaldo, São Paulo, Brazil. luara@usp.br
authors.forename: Luara B
authors.initials: LB
authors.lastname: Almeida
authors.forename: Aluisio C
authors.initials: AC
authors.lastname: Segurado
authors.forename: Ana Clara F
authors.initials: AC
authors.lastname: Duran
authors.forename: Patricia C
authors.initials: PC
authors.lastname: Jaime
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015992:Body Mass Index; D001938:Brazil; D003376:Counseling; D019587:Dietary Supplements; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009751:Nutritional Requirements; D009752:Nutritional Status; D010353:Patient Education as Topic; D011379:Prognosis; D015397:Program Evaluation; D012959:Socioeconomic Factors; D055815:Young Adult